Eli Lilly (LLY) has reportedly sent out cease-and-desist letters to compounding pharmacies and clinics that were providing copycat versions of its drugs Zepbound and Mounjaro.
(Reuters) - EliLilly is investing $1.8 billion across two manufacturing ... especially for its top-selling diabetes and obesity drugs, Mounjaro and Zepbound, respectively. The company has ...